Home NDC 70010-227 Gabapentin
Product NDC 70010-227
11-digit product format 700100227
Labeler code 70010
Product ID 70010-227_5d4eef8d-99c1-6615-e063-6294a90a891c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Gabapentin
Dosage form TABLET, FILM COATED
Route ORAL
Labeler Granules Pharmaceuticals Inc.
Application ANDA217116
Marketing category ANDA
Marketing start 2023-06-27
Substance GABAPENTIN
Active strength 600 mg/1
Pharmacologic classes Decreased Central Nervous System Disorganized Electrical Activity [PE]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 44 .
Orange Book products# Current product rows page 1 of 1 · 2 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A217116-001 GABAPENTIN GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 A217116-002 GABAPENTIN GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 2 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 52 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-10-15 13:18:30 2026-09 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 c2088c7a36db…2026-10-15 13:18:30 2026-09 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 c2088c7a36db…2026-09-14 22:38:34 2026-08 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 84e616aacf4f…2026-09-14 22:38:34 2026-08 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 84e616aacf4f…2026-08-18 06:07:40 2026-07 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 caaa826d4ba7…2026-08-18 06:07:40 2026-07 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 d06236e962d9…2024-10-29 15:01 UTC 2024-10 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 8072bd15b7f6…2024-05-31 18:47 UTC 2024-05 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 6a51e52b5d6a…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB1 2023-03-28 1c564ffb4f44…2024-02-18 07:12 UTC 2024-02 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB1 2023-03-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A217116-001 GABAPENTIN 600MG TABLET / ORAL AB 2023-03-28 ea1830bbd6c7…2023-12-20 04:57 UTC 2023-12 A217116-002 GABAPENTIN 800MG TABLET / ORAL AB 2023-03-28 ea1830bbd6c7…
Observed Orange Book normalized TE history# Normalized TE history page 2 of 2 · 52 observed states.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base Gabapentin
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength GABAPENTIN 600 mg/1
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 70010-227-01 Gabapentin 100 in 1 BOTTLE TABLET, FILM COATED 100 4 70010-227-05 Gabapentin 500 in 1 BOTTLE TABLET, FILM COATED 500 4
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70010-227 GABAPENTIN TABLET, FILM COATED [GRANULES PHARMACEUTICALS INC.] 3 Current NDC, 2 package rows 20241018_e847bcfa-f3de-404a-8a57-d8a414691e6a.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 70010-227-01 70010022701 100 TABLET, FILM COATED in 1 BOTTLE (70010-227-01) 2023-06-27 No No Current 70010-227-05 70010022705 500 TABLET, FILM COATED in 1 BOTTLE (70010-227-05) 2023-06-27 No No Current